October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Nirmala Bhoo Pathy: C/Can is looking for an experienced consultant to help improve cancer care quality in Greater Petaling
Oct 18, 2024, 15:30

Nirmala Bhoo Pathy: C/Can is looking for an experienced consultant to help improve cancer care quality in Greater Petaling

Nirmala Bhoo Pathy shared on Linkedin:

City Cancer Challenge (C/Can) is looking for an experienced consultant to contribute to improving cancer care quality in Greater Petaling.

This is your opportunity to help align local cancer care standards with global best practices.

Why this role matters:

You’ll play a key role in shaping the implementation of Quality Cancer Care Indicators (QCCIs) in Greater Petaling, helping the region advance toward equitable, high-quality cancer care.

We’re looking for:

Someone with experience in Malaysia’s cancer care system and public health policy, ready to analyze, advise, and offer clear, actionable solutions.

How to apply:

Submit your CV and cover letter by October 31, 2024, to [email protected] (CC: [email protected]).”

Nirmala Bhoo Pathy: C/Can is looking for an experienced consultant to help improve cancer care quality in Greater Petaling

Nirmala Bhoo-Pathy is a Professor of Epidemiology in the Department of Social and Preventive Medicine, Faculty of Medicine, University Malaya, and practices as a public health physician at the University Malaya Medical Centre, Malaysia. She is also a visiting scholar at Queen’s University Belfast, United Kingdom since 2014. Dr Bhoo Pathy’s career is focused on optimizing life after cancer in resource-limited settings through research and advocacy.

Dr Bhoo Pathy was the principal investigator of phase III of the ASEAN CosTs In ONcology (ACTION) study, comprising close to 10,000 cancer patients from eight low-and middle-income member countries of the Association of South East Asian Nations (ASEAN). She currently serves in two Lancet Commissions: the Lancet Commission on Women and Cancer and the Lancet Commission on Cancer and Health Systems.